ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,246Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 25

$760K Total Retail Price of All Prescriptions

Rank: 1 out of 25

292 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 292 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

9% of this provider’s 292 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 7,788 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 528 353 1 1
WARFARIN SODIUM 401 270 2 10
AMLODIPINE BESYLATE 363 234 3 2
SIMVASTATIN 358 294 4 3
TRAMADOL HCL 281 163 5 13
RANITIDINE HCL 255 165 6 16
METFORMIN HCL 252 199 7 8
METOPROLOL TARTRATE 237 164 8 9
GABAPENTIN 234 121 9 30
MIRTAZAPINE 219 141 10 24
FUROSEMIDE 211 142 11 7
LACTULOSE 205 135 12 43
QUETIAPINE FUMARATE 182 97 13 31
PRAVASTATIN SODIUM 181 95 14 6
LANTUS 177 127 15 46
DIVALPROEX SODIUM 170 123 16 39
TRAZODONE HCL 163 82 17 26
METOPROLOL SUCCINATE 160 101 18 12
ATORVASTATIN CALCIUM 154 88 19 14
LEVETIRACETAM 151 91 20 42
CITALOPRAM HBR 147 113 21 23
HYDROCODONE-ACETAMINOPHEN 144 122 S3 22 19
LEVOTHYROXINE SODIUM 142 109 23 5
RISPERIDONE 122 84 24 35
OMEPRAZOLE 120 59 25 15
OXYCODONE-ACETAMINOPHEN 118 87 S2 26 21
CLONIDINE HCL 115 51 27 25
OLANZAPINE 114 80 28 62
LOSARTAN POTASSIUM 110 69 29 29
DONEPEZIL HCL 103 81 30 27
SEROQUEL 102 67 31 49
NIFEDIPINE ER 102 66 31 69
LAMOTRIGINE 97 48 33 52
ADVAIR DISKUS 91 52 34 52
OXYCODONE HCL 90 38 S2 35 4
CLOPIDOGREL 90 60 35 37
HYDROCHLOROTHIAZIDE 90 57 35 11
BENZTROPINE MESYLATE 89 43 R 38 72
HALOPERIDOL 88 29 39 73
HYDRALAZINE HCL 86 57 40 58
POTASSIUM CHLORIDE 81 47 41 28
PANTOPRAZOLE SODIUM 80 42 42 18
CARBIDOPA-LEVODOPA 79 64 43 77
CARVEDILOL 78 55 44 56
CRESTOR 78 67 44 32
DIGOXIN 74 28 46 83
IBUPROFEN 72 27 47 32
ZOLPIDEM TARTRATE 68 25 48 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 48 49 22
ACETAMINOPHEN-CODEINE 66 66 S3 50 89
NITROGLYCERIN PATCH 65 54 51 91
LABETALOL HCL 62 27 52 94
FLUOXETINE HCL 61 39 53 60
SPIRIVA 59 29 54 99
NEXIUM 58 22 55 48
GEMFIBROZIL 58 45 55 101
PERPHENAZINE 56 31 57 102
VENTOLIN HFA 56 47 57 102
GLIPIZIDE 54 49 59 108
GLYBURIDE 53 39 R 60 112
FLUTICASONE PROPIONATE 52 30 61 66
DIOVAN 51 37 62 115
CYMBALTA 51 25 62 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 26 62 65
BACLOFEN 51 20 62 115
KLOR-CON M20 50 22 66 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.